GB:0R3M Stock Latest News
Company AnnouncementsVivoryon to Release Q3 Results as Funding Talks for Kidney Drug Advance2d ago
Company AnnouncementsVivoryon Shareholders Back Board and Strategy at 2026 AGM1M ago
Company AnnouncementsVivoryon Sets Date for 2026 AGM as Kidney Disease Program Advances2M ago
Company AnnouncementsVivoryon narrows H1 loss as it pursues partners for kidney drug varoglutamstat2M ago- Company AnnouncementsVivoryon to Present H1 2026 Results and Schedule AGM3M ago
Company AnnouncementsVivoryon Therapeutics AG: Progress Amid Financial Challenges1y agoCompany AnnouncementsVivoryon Therapeutics Unveils Promising R&D Progress in Kidney Disease Treatment1y ago
Company AnnouncementsVivoryon Advances Kidney Disease Drug with Promising Results and Expanded Patent Portfolio1y ago- Company AnnouncementsVivoryon Therapeutics Advances Kidney Disease Treatments1y ago
Company AnnouncementsVivoryon Reports Positive Kidney Function Study Results1y ago
Company AnnouncementsVivoryon Therapeutics Reports Promising Kidney Drug Results2y ago
Company AnnouncementsVivoryon Therapeutics Showcases New Kidney Disease Treatment2y ago
Company AnnouncementsVivoryon Therapeutics Announces Upcoming Financial Results and KOL Event2y ago
Company AnnouncementsVivoryon’s Drug Shows Promise for Diabetic Kidney Health2y ago- Company AnnouncementsVivoryon Therapeutics AG: R&D Update Call2y ago
- Company AnnouncementsVivoryon Therapeutics AGM Concludes Successfully2y ago